The NCPE will not be processing RR/HTA submissions between December 21st 2018 and 2nd January 2019 (incl). Final date for receipt of submissions will be Thursday 20th December 2018. We would like to wish all a Happy Christmas and Peaceful New Year.
The NCPE recommends that lesinurad not be considered for reimbursement. This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.
A date for your diary: the next course an "Update on Pharmacoeconomics in the Irish Healthcare Setting" will take place on 15th & 16th May 2019 in Dublin Castle. Places now available.